Sanofi’s Appeal Against PTAB Draws Industry-Wide Attention on Patent Law Precedents
Sanofi’s subsidiary is drawing attention as it challenges the way the Patent Trial and Appeal Board (PTAB) addresses obviousness-type double patenting. This appeal has gained substantial backing from technology and biopharma giants such as Canon and Sonos, highlighting the case’s significance across industries. The legal community is closely watching this matter for its potential impact…